
Biospeciman
About Biospeciman
Biospeciman is a Healthcare company, and was acquired by Brooks Automation in April 2018. Automated sample storage and handling systems are manufactured.
Company details
Automated cryogenic and cold storage systems, along with sample management software, are manufactured in the biotechnology sector. Consumables and instruments for sample handling are supplied, while services such as storage, relocation, and transportation are provided. Laboratory information management systems for biobanking and cell line management are offered. These products and services support operations in research, clinical trials, and biopharmaceutical manufacturing.
- Stage Acquired
- SectorsHealthcare
- Website biospeciman.com
- Acquired by Brooks Automation (Apr 2018)
- Investors
- Acquired byBrooks Automation
(Apr 2018)
Investors in Biospeciman
Biospeciman has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Brooks Automation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Vacuum robots for semiconductor wafer handling are developed. | 1978 | brooks.com | Chelmsford, United States |
Investor details for Biospeciman
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biospeciman
Automated cryogenic and cold storage systems, along with sample management software, are manufactured in the biotechnology sector. Consumables and instruments for sample handling are supplied, while services such as storage, relocation, and transportation are provided. Laboratory information management systems for biobanking and cell line management are offered. These products and services support operations in research, clinical trials, and biopharmaceutical manufacturing.
Biospeciman has 1 investor. Key investors include Brooks Automation.
Yes. Biospeciman was acquired by Brooks Automation in April 2018.